Income Tax Department Appeals Tribunal Ruling on Employee Stock Option Plan Tax Relief for Dr Lal Pathlabs

The Income Tax Department has filed an appeal against a decision that provided Dr Lal PathLabs with tax relief. This relief was related to Employee Stock Option Plan (ESOP) expenses amounting to ₹32,66,18,927 for the Assessment Year 2022-23. The dispute is now heading to the Income Tax Appellate Tribunal in New Delhi for a decision.

This development means the tax treatment of these ESOP expenses is once again a point of contention. The appeal itself does not finalize whether the company can claim these expenses for tax purposes. Dr Lal PathLabs’ shares saw a decrease of 2.38 percent, closing at ₹1,898.90 on October 8, 2026, amidst a general weakening of the broader market.

The Case Moves to a Higher Appellate Stage

The issue began with an assessment order received by Dr Lal PathLabs on April 1, 2024, which addressed the disallowance of ESOP expenses. The amount in question is the expense claimed by the company, not a direct tax bill. On July 17, 2026, the Commissioner of Income Tax (Appeals) issued an order that granted relief to the company under Section 250 of the Income Tax Act, 1961. The Income Tax Department has now challenged this specific order before the tribunal. This progression places the matter at a further appellate stage, with the core question remaining whether the ESOP-related expenditures are eligible for tax deduction in Assessment Year 2022-23.

Company’s Stance on Material Impact

Dr Lal PathLabs has stated that it does not anticipate the outcome of this appeal to have any significant effect on the company. This assessment is based on management’s current understanding of the proceedings and their potential financial or operational consequences. While the company does not foresee a material impact, this is a forward-looking statement and not a definitive conclusion on the eventual tax implications.

Market Reaction Amidst Broader Weakness

The decline in Dr Lal PathLabs’ share price occurred on a day when the overall stock market also experienced a downturn. This broader market weakness suggests that the appeal filed by the Income Tax Department may not be the sole reason for the stock’s movement. The table below provides market figures for context:

Market Measure	Reported Figure
NSE Close (Oct 8, 2026)	₹1,898.90
Previous Close	₹1,945.10
Daily Change	Down ₹46.20 (2.38%)
Trailing P/E Ratio	59.76
Market Capitalization	Approx. ₹31,873 crore
Year-to-Date Return	25.70%

These market figures offer a snapshot of the trading day but do not definitively establish the cause of the stock’s performance. The appeal’s timing coincided with the share price drop and the general market decline.

Tribunal to Determine Expense Dispute

The appeal currently before the Income Tax Appellate Tribunal is not a final judgment on whether the ESOP expenses are deductible or disallowed. The tribunal has the authority to uphold, alter, or overturn the previous appellate order. Any further appeals would follow this determination. The department’s challenge specifically targets the tax treatment of these expenses for Assessment Year 2022-23, and the tribunal will be the next body to make a substantive decision on this matter.

Frequently Asked Questions